Stop TB USA

Stop TB USAStop TB USAStop TB USA
Home
About Us
  • Our History
  • Leadership
Resources
  • About TB
  • Letter to the Editors
  • TB Wire
Get Involved
  • Our Work Groups
  • Donate Now!
  • Contact Us
  • Become a Member

Stop TB USA

Stop TB USAStop TB USAStop TB USA
Home
About Us
  • Our History
  • Leadership
Resources
  • About TB
  • Letter to the Editors
  • TB Wire
Get Involved
  • Our Work Groups
  • Donate Now!
  • Contact Us
  • Become a Member
More
  • Home
  • About Us
    • Our History
    • Leadership
  • Resources
    • About TB
    • Letter to the Editors
    • TB Wire
  • Get Involved
    • Our Work Groups
    • Donate Now!
    • Contact Us
    • Become a Member
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • About Us
    • Our History
    • Leadership
  • Resources
    • About TB
    • Letter to the Editors
    • TB Wire
  • Get Involved
    • Our Work Groups
    • Donate Now!
    • Contact Us
    • Become a Member

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

What is TB?

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs but can also impact other parts of the body, such as the kidneys, spine, and brain. TB spreads through the air when individuals with active pulmonary TB cough, sneeze, or speak, releasing bacteria into the environment.​

How Is TB Treated?


TB is treatable and curable with a regimen of antibiotics. Standard treatment for active TB disease involves a minimum 6-month course of at least four antibiotics: isoniazid, rifampicin, pyrazinamide, and ethambutol. It's crucial to complete the entire treatment to prevent the development of drug-resistant TB strains.


For TB infection (aka LTBI), where the bacteria are present but inactive, treatment options are shorter and may include a 3-month regimen of isoniazid and rifapentine or a 4-month course of rifampicin alone.​

How Common Is TB?


TB remains the top infectious killer disease globally. In 2023, approximately 10 million people fell ill with TB, and 1.25 million died from the disease, making it the leading cause of death.


While TB is more prevalent in low- and middle-income countries, it also affects high-income nations. In the United States, TB cases rose to over 10,300 in 2024, the highest since 2011, with notable outbreaks in states like Kansas.

  • Our Work Groups

Where We Unite To #EndTB

Copyright © 2025 Stop TB USA - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept